U.S. Machinery Stock News

NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

Is It Time To Reassess Bio-Techne (TECH) After Years Of Share Price Weakness?

If you are wondering whether Bio-Techne is attractively priced or just fairly valued right now, you are in the right place to put some structure around that question. Bio-Techne's share price last closed at US$66.78, with returns of 2.3% over 7 days, 1.6% over 30 days, 12.0% year to date, but a 3.9% decline over 1 year, a 12.2% decline over 3 years and a 31.7% decline over 5 years. Recent attention on the stock has been shaped by ongoing interest in life sciences tools companies and how...
NYSE:PSTG
NYSE:PSTGTech

Hesai Group And 2 Other Stocks That May Be Priced Below Intrinsic Value

As the United States stock market kicks off February with a strong surge, evidenced by the Dow Jones Industrial Average's 515-point gain and the S&P 500 nearing record highs, investors are keenly observing which stocks could be undervalued amidst this positive momentum. In such an environment, identifying stocks that may be priced below their intrinsic value can present opportunities for investors looking to capitalize on potential growth while navigating current economic developments.
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Three High Growth Companies With Significant Insider Ownership

As February begins, major U.S. stock indexes have started the month on a high note, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing record levels. In this buoyant market environment, investors often look for growth companies with significant insider ownership as these stocks can indicate strong confidence from those closest to the business.
NasdaqGS:NMRA
NasdaqGS:NMRAPharmaceuticals

3 Promising Penny Stocks With Market Caps Up To $400M

The U.S. stock market kicked off February with a strong performance, as major indexes like the Dow Jones and S&P 500 posted significant gains. Amidst this backdrop of optimism, investors are exploring various opportunities across different market segments. While penny stocks might seem like a throwback to earlier trading days, they continue to offer intriguing possibilities for those interested in smaller or emerging companies with potential growth prospects.
NasdaqGS:CTBI
NasdaqGS:CTBIBanks

Discovering US Market's Undiscovered Gems in February 2026

As February 2026 unfolds, the U.S. stock market has kicked off the month with a robust upswing, as evidenced by significant gains in major indices like the Dow Jones Industrial Average and S&P 500. Amid this bullish sentiment, small-cap stocks are garnering attention due to their potential for growth and resilience in a fluctuating economic landscape. In this dynamic environment, identifying promising stocks requires an understanding of how these companies can capitalize on current market...
NYSE:YRD
NYSE:YRDConsumer Finance

Top Dividend Stocks To Consider In February 2026

As February 2026 begins, U.S. stock markets have surged with the Dow Jones Industrial Average climbing by 515 points and the S&P 500 nearing record highs, reflecting a positive start to the month despite ongoing economic uncertainties such as trade negotiations and government shutdowns. In this environment of market optimism, dividend stocks can offer investors a compelling combination of potential income and stability, making them an attractive consideration for those looking to navigate...
NYSE:VTR
NYSE:VTRHealth Care REITs

Why Ventas (VTR) Is Up 6.6% After Dividend Hike And 2026 Earnings Guidance And What's Next

Ventas, Inc. recently reported its fourth-quarter and full-year 2025 results, showing higher revenue of US$1.57 billion and net income of US$70.20 million for the quarter, alongside an 8% increase in its quarterly dividend to US$0.52 per share payable on April 16, 2026. Management also issued 2026 guidance for attributable net income per share of US$0.52–US$0.62 and funds from operations of US$3.78–US$3.88 per share, underscoring how senior housing investments and improved operating metrics...
NasdaqCM:KARO
NasdaqCM:KAROSoftware

How Cartrack’s Schmitz Cargobull Telematics Integration Will Impact Karooooo (KARO) Investors

Karooooo’s subsidiary Cartrack recently partnered with Schmitz Cargobull to integrate TrailerConnect® telematics data into Cartrack’s fleet management platform, giving transport operators real-time trailer visibility without new hardware installation. This collaboration deepens Cartrack’s role in logistics by consolidating temperature, location, route, and load-condition data to help improve efficiency, compliance, and safety for transport operators. We’ll examine how this enhanced real-time...
NYSE:DKS
NYSE:DKSSpecialty Retail

DICK'S Outdoor Store Reset After Moosejaw Closures Might Change The Case For Investing In DICK'S Sporting Goods (DKS)

DICK'S Sporting Goods recently closed its Moosejaw stores, folding the acquired outdoor retailer into its Public Lands format while also cutting back the Public Lands store count. This consolidation marks a broad reset of the company’s outdoor footprint, highlighting management’s willingness to rethink underperforming concepts and reallocate resources. We’ll now examine how this reset of DICK’S outdoor footprint, including Moosejaw closures and fewer Public Lands stores, shapes its...
NasdaqGS:NBTB
NasdaqGS:NBTBBanks

Is Earnings Upswing And 13th Dividend Hike Altering The Investment Case For NBT Bancorp (NBTB)?

NBT Bancorp Inc. reported past fourth-quarter 2025 results with net interest income of US$135.44 million and net income of US$55.51 million, alongside a higher full-year 2025 profit versus 2024 and announced a first-quarter 2026 dividend of US$0.37 per share. The board’s decision to lift the quarterly dividend for a thirteenth consecutive year, alongside ongoing share repurchases, highlights a continued emphasis on shareholder returns. Next, we’ll examine how this earnings improvement and...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

Is BeOne Medicines (ONC) Using InSysBio Partnership to Quietly Redefine Its R&D Risk Strategy?

InSysBio recently announced it has extended its collaboration with BeOne Medicines to apply mechanistic translational modeling to support selection of minimal recommended starting doses, step-up dosing regimens, and dose-escalation clinical study design for cytokine release syndrome risk management. This expanded partnership highlights how advanced modeling can shape early clinical decisions, potentially improving the efficiency and safety profile of BeOne Medicines’ development...
NasdaqCM:HNRG
NasdaqCM:HNRGRenewable Energy

3 Undervalued Small Caps With Insider Buying Opportunities

As February begins, the U.S. stock market is experiencing a positive start with major indices like the Dow Jones and S&P 500 showing strong performances. This optimistic trend, coupled with evolving economic indicators such as manufacturing growth and trade developments, creates an intriguing backdrop for exploring small-cap stocks that may present unique opportunities in today's dynamic market environment.